Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma

Overview of attention for article published in JAMA Oncology, December 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 16 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 125 X users
reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 163 X posts from 125 X users, with an upper bound of 703,449 followers.

RT @oncologistindia: Cabozantinib for Treatment of Brain Metastases in Patients With #RenalCellCarcinoma https://t.co/GZQYvHdZUE @Amolpate…

Cabozantinib for Treatment of Brain Metastases in Patients With #RenalCellCarcinoma https://t.co/GZQYvHdZUE @Amolpatel_dr @amitjoshi2 @SewantiLimaye https://t.co/D4o4hlLYkG

RT @DrChoueiri: 1/ Happy to share with you our latest work in @JAMAOnc “Clinical Activity and Safety of Cabozantinib for Brain Metastases i…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 159 additional X posts.